https://www.indianpharmapost.com/granules-india-receives-form-483-with-1-observation-from-usfda-for-bonthapally-api-unit-1-172962025-06-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/sai-life-sciences-commences-commercial-operation-of-2nd-phase-in-bidar-172972025-06-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/cohance-lifesciences-to-sell-cr-bio-assets-to-chromo-laboratories-india-for-rs-16-cr-172982025-06-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/emcure-to-acquire-remaining-stake-in-zuventus-healthcare-172992025-06-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/unichem-receives-form-483-from-usfda-with-3-observations-for-roha-api-facility-173002025-06-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/basf-opens-new-gmp-solution-center-in-us-173012025-06-23T00:00:00+05:30always0.9